Excipient: Super Refined™ PEG 400
Product Description
Croda Europe Limited
-
GB -
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
.jpg)
Categories
Specifications
Croda Europe Limited
-
GB
-
2015On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
More Products from Croda Europe Limited (24)
-
Product Super Refined™ GTCC
Super Refined™ GTCC:Super Refined GTCC is a high purity mixed ester consisting primarily of the saturated fatty acids caprylic (C8) and capric (C10) acid. Products of this type are commonly referred to as medium chain triglycerides (MCT) and they possess a number of useful properties in nutritional and top... -
Product Super Refined™ L18 POG
Super Refined™ L18 POG:Super Refined™ L18 POG is a high purity mixture of mono-, di-, and triesters of glycerol, and mono- and diesters of polyethylene glycols, with the predominant fatty acid concentration stemming from linoleic acid. It is a low HLB emulsifier and solubiliser of poorly water soluble Acti... -
Product Super Refined™ O18 POG
Super Refined™ O18 POG:Super Refined™ O18 POG is a high purity mixture of mono-, di-, and triesters of glycerol, and mono- and diesters of polyethylene glycols with the predominant fatty acid concentration stemming from oleic acid. It is a low HLB emulsifier and solubiliser of poorly water soluble Active P... -
Product Super Refined™ PEG 300
Super Refined™ PEG 300:Super Refined PEGs are solvents for use with the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes polar impurities (including primary and secondary oxidation products) from an excipient without altering its chemical compositi... -
Product Super Refined™ PGML
Super Refined™ PGML:Super Refined™ PGML is a high purity mixture of propylene glycol and esters of lauric (C12) acid. More specifically, as part of the Type II classification, it has at least a 90% concentration of monoesters, with the remaining percentage being diesters. In addition to being a low HLB emu... -
Product Tween™ 80 HP
Tween™ 80 HP: • Tween™ 80 HP goes beyond standard polysorbate monograph requirements to provide a low moisture, low peroxide version of Tween 80 designed for parenteral applications and applications where API stability presents a challenge • O/W emulsifier, solubiliser and wetting agent • An additional h... -
Product Excipient: Super Refined™ Polysorbate 80
Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to red... -
Product Excipient: Super Refined™ Polysorbate 20
Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to red... -
Product Vaccine Adjuvant: Alhydrogel™
• Alhydrogel is a range of aluminium hydroxide gel products which have been specifically developed for use as an adjuvant in human and veterinary vaccines • The gel is a suspension of boehmite-like (aluminium oxyhydroxide) hydrated nano/micron size crystals in loose aggregates • The products have v... -
Product Excipient: Super Refined™ DEGEE
Super Refined DEGEE is ideal for use in topical and transdermal applications to enhance the permeation of poorly water-soluble API’s through various layers of the skin, thereby improving drug delivery. It can also be used as a co-solvent in self-emulsifying drug delivery systems (SEDDS), or self-microe... -
Product Excipient: Super Refined™ P35 Caster Oil
Super Refined P35 Castor Oil is a castor oil derivative, resulting from the reaction of glycerol ricinoleate and 35 mols of ethylene oxide. This product is a liquid nonionic solubiliser and emulsifier, characteristic of a slightly yellow hue, and is intended for use in parenteral, ophthalmic, oral, and... -
Product Vaccine Adjuvant: Quil-A™
• Quil-A is a highly purified and concentrated saponin adjuvant purified from bark extract of the Quillaja saponaria Molina tree which has been specifically developed for use as an adjuvant in vaccines • Quil-A saponin was originally purified and characterised by Dr. Pharm • Kristian Dalsgaard in 1...
Croda Europe Limited resources (14)
-
Sponsored Content Croda: Solutions for Your High Value Drug Products
Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs are prone to degradation when exposed to various chemical species. -
Brochure Addressing the challenges of vaccine formulation
To this day, our focus has been to successfully develop, manufacture and market high-quality adjuvants for our pharmaceutical customers. This heritage makes our vaccine adjuvants unique in the industry. A heritage we are proud of.
Our industry-leading, Alhydrogel®, Adju-Phos® and Quil-A® are widely recognised in the vaccine industry for their unmatched track record when it comes to a proven history of safe and effective use. -
Sponsored Content Avanti & Croda-Denmark: Advancing Vaccine Adjuvant Research
Adjuvants. You’ve seen them on our website. You’ve seen them featured in our blog articles. Now we want to show you how Avanti’ & Croda-Denmark can enhance your vaccine adjuvant research!
Keep reading to learn more!
-
Brochure Avanti cGMP Manufactured Lipids
For over 40 years Avanti has provided API (Active Pharmaceutical Ingredient) Technology Development for Pharmaceutical and Biotechnology companies. Our unique reputation for quality in the development of pre-clinical and clinical candidates is well established. Our full range of services include process chemistry, scale-up manufacturing, supply chain management with analytical and regulatory requirements. Avanti’s experienced staff of chemists and lipid analysts are ready to meet your development needs with pre-clinical through phase III and commercial launch. -
News Top 5 Industry Content Reads on CPHI Online This Month
If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partner.
-
Brochure Croda Mill Hall press release
Croda International Plc, the company that uses smart science to create high performance ingredients and technologies that improve lives, is excited to announce the expansion of its Mill Hall high purity excipients facility. This investment confirms Croda’s commitment to building its Life Sciences business and developing innovative pharmaceutical excipients, reinforcing Croda’s Purpose to use Smart science to improve lives™. With this latest Mill Hall expansion, Croda continues their ambitious target to become People Positive by 2030 by contributing to the successful development of 25% of WHO-listed pipeline vaccines.
To find out more, please visit: https://www.croda.com/en-gb/news/2021/08/croda-expands-its-high-purity-pharmaceutical-excipients-manufacturing-capability -
.jpg)
News Construction underway on new Croda North American HQ and Innovation Centre
The facility will support the company'a goal of being climate, land and people positive by 2030. -
Technical Data Polysorbates for Biopharma
Super Refined™ Polysorbates for Biopharma applications.
This document is relevant to the following market areas
Health Care - DermaHealth Care - Pharma
Health Care - Nutra
Health Care - Animal Health
This document is attached to the following products
Super Refined™ Polysorbate 80 -
News Croda bolsters position in life sciences with the acquisition of Avanti Polar Lipids
The transaction will more than double Croda’s R&D capability in drug delivery. -
Technical Data Pharmaceutical excipients for ophthalmic formulations
Pharmaceutical excipients for ophthalmic formulations.
This document is relevant to the following market areas
Health Care - Derma
Health Care - Pharma
Health Care - Nutra
Health Care - Animal Health -
News Croda commits to Science Based Targets for reduction of greenhouse gas emissions
Group aiming to achieve a 50% reduction in absolute GHG emissions based on 2006 levels by 2030 and an 80% reduction by 2050. -
Technical Data Super Refined™ pharmaceutical excipients
Super Refined™ pharmaceutical excipients. -
Video Supporting the World's Biggest Challenges
Smart Science to Improve Lives. For more than 75 years Croda Denmark has been dedicated to safe and effective adjuvants for use in both human and veterinary vaccines, as well as blood fractioning processes. We offer an experienced passionate team and personal interaction with comprehensive on-site advice and support anywhere in the world. -
Webinar Formulation solutions for cannabinoids
The use of cannabinoids (CBD) is a growing marketplace dominated by oral and topical formulations. Croda offers Super Refined™ formulation solutions providing benefits such as; improving stability and reducing taste impact. Find out more here:
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance